MXCT
MaxCyte Inc
NASDAQ: MXCT · HEALTHCARE · MEDICAL DEVICES
$0.84
-3.24% today
Updated 2026-05-08
Market cap
$90.34M
P/E ratio
—
P/S ratio
2.74x
EPS (TTM)
$-0.42
Dividend yield
—
52W range
$1 – $2
Volume
0.9M
MaxCyte Inc (MXCT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-135.10%
Operating margin
-94.80%
ROE
-23.60%
ROA
-12.60%
Debt/equity
0.10x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $5.06M | $-1.99M | 83.59% | -38.79% | -39.30% |
| 2013 | $6.80M | $-958200.00 | 88.12% | -11.83% | -14.08% |
| 2014 | $7.16M | $-1.84M | 86.64% | -17.81% | -25.64% |
| 2015 | $9.29M | $-1.45M | 88.89% | -8.19% | -15.56% |
| 2016 | $12.27M | $-3.35M | 89.34% | -22.20% | -27.27% |
| 2017 | $13.98M | $-9.92M | 89.61% | -66.44% | -70.91% |
| 2018 | $16.67M | $-8.87M | 88.96% | -50.55% | -53.21% |
| 2019 | $21.62M | $-12.89M | 88.44% | -57.44% | -59.64% |
| 2020 | $26.17M | $-11.82M | 89.43% | -42.25% | -45.15% |
| 2021 | $33.89M | $-19.08M | 89.24% | -53.66% | -56.30% |
| 2022 | $44.26M | $-23.57M | 88.48% | -61.82% | -53.25% |
| 2023 | $41.29M | $-37.92M | 88.51% | -116.98% | -91.85% |
| 2024 | $38.63M | $-41.05M | 81.62% | -132.54% | -106.29% |
| 2025 | $33.03M | $-44.63M | 68.36% | -131.85% | -135.14% |